Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Narrowband UVB therapy significantly improved a child's rare skin condition.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Trichoscopy is crucial for diagnosing rare genetic hair disorders.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Vitamins A, B, C, and D are important for skin health and are being explored for new uses, but more research is needed to confirm their effectiveness.

Accurate diagnosis of hyperandrogenism, especially PCOS, is crucial for managing fertility and metabolic risks in women.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Cathepsin L deficiency causes hair and skin issues in mice.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Early surgical intervention and a multidisciplinary approach are crucial for managing complex cardio-obstetric patients.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

New-onset fibromyalgia after COVID-19 is poorly understood, needing better definitions and studies.

A rare scalp disease causes hair loss, pus-filled nodules, and scarring.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Oestrogens are key for bone growth during puberty in both boys and girls.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.